Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior

McGuire, John F.; Ge, Norman N.; Dyson, Senait W.

doi:10.1016/j.amjoto.2008.03.002

Cited by 91 publications

(55 citation statements)

References 111 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…15 Six patients in our series had a history of local trauma before the development of DFSP, and the interval between the trauma and development of DFSP varied. Tattoo sites also show a predilection for benign and malignant changes and should be evaluated during regular skin examinations; DFSP should be considered in the differential diagnosis of neoplasms arising within areas of tattoos.…”

Section: Discussionmentioning

confidence: 89%

Imaging Findings of Head and Neck Dermatofibrosarcoma Protuberans

Millare

Guha-Thakurta²,

El‐Naggar

et al. 2013

American Journal of Neuroradiology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 89%

Imaging Findings of Head and Neck Dermatofibrosarcoma Protuberans

Millare

Guha-Thakurta²,

El‐Naggar

et al. 2013

American Journal of Neuroradiology

View full text Add to dashboard Cite

show abstract

“…При ис-пользовании неодимового лазера при первичных опухолях рецидивы составляют 1,1-3,8%, при ре-цидивных -4,8-5,6%. При использовании СО 2 -лазеров эти показатели достигают 2,8% и 5,7-6,9% соответственно [1,26].…”

Section: клиническая дерматология и венерология 3 2015unclassified

“…Лучевая терапия. В последние годы применение лучевой терапии снизилось в связи с патогенетиче-ской значимостью радиации и инсоляции в развитии БКРК и его рецидивов [22,26]. Также для метода ха-рактерен ряд недостатков: лучевой дерматит, рубцо-вая алопеция, дистрофия кожи, нарушения пигмен-тации, пойкилодермия.…”

Section: противопоказания для лазеротерапииunclassified

Modern methods of basal-cell carcinoma treatment

Vasilevskaya¹,

Vardanyan²,

Dzybova³

2015

Klin. dermatol. venerol.

View full text Add to dashboard Cite

“…The majority of skin cancers are diagnosed by primary care physicians and dermatologists who are able to successfully treat these lesions by simple, local extirpation which is curative in most cases [3]. However, some patients with more complex locally metastatic or recurrent disease may be seen by otolaryngologists-head and neck surgeons for NMCC of the head and neck.…”

Section: Introductionmentioning

confidence: 99%

Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas

Huoh¹,

Wang

2011

TOOTORJ

View full text Add to dashboard Cite

Abstract:Objectives: Head and neck nonmelanoma cutaneous carcinomas (NMCC) may have poor outcomes, such as metastasis and recurrence. It remains unclear which patients are at increased risk for poor outcomes. We characterize a population of NMCC seen in a head and neck surgical practice. We sought to identify predictors of poor outcome in head and neck NMCC.Study Design: A retrospective cohort study of 161 patients with head and neck NMCC who presented to a university based otolaryngology-head and neck surgery practice over a 13 year period was performed. The study group included 127 men and 34 women, age range: 33 -92 years. Subjects and Methods:Tumor characteristics of the study population were recorded, and statistical analysis and KaplanMeier survival calculations were performed to determine predictors of poor outcomes.Results: 113 squamous cell carcinomas (SCC) and 48 basal cell carcinomas (BCC) were identified. Among SCC patients, there was a 44% incidence of metastasis and a 47% incidence of recurrence. Among BCC patients, there was a 10% incidence of metastasis and a 50% incidence of recurrence. Twenty percent of SCC patients had a history of immunosuppression. Among SCC patients with immunosuppression, 83% had metastasis or recurrence. Survival for SCC patients with metastatic disease was significantly worse than patients without metastases. The presence of parotid metastases in SCC conferred a survival advantage when compared to other sites of metastases. Conclusion:The incidence of poor outcomes in NMCC was higher in our series than reported in the literature. Survival patterns of our study parallel those of similar studies in the literature.

show abstract

Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior

Cited by 91 publications

References 111 publications

Imaging Findings of Head and Neck Dermatofibrosarcoma Protuberans

Imaging Findings of Head and Neck Dermatofibrosarcoma Protuberans

Modern methods of basal-cell carcinoma treatment

Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas

Contact Info

Product

Resources

About